Paroxetine Unicorn 20 20 mg Tablets.
PDF Leaflet Revision Date: 01 Aug 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depression and anxiety disorders.
Dosage (summary)
20 mg daily, may increase by 10 mg increments; max 50 mg for depression, 60 mg for panic disorder/OCD.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not established; potential risks in pregnancy and lactation.
Key Drug Interactions
- MAO inhibitors
- Serotonin precursors
- Pimozide
- Risperidone
- Alcohol
Contraindications
- Hypersensitivity
- Children under 18
- Seizures
- Porphyria
Common side effects
- Nausea
- Dizziness
- Somnolence
- Insomnia
- Dry mouth
Counselling Points
- Take with food in the morning
- Avoid abrupt discontinuation
- Monitor for suicidal thoughts
- Caution with alcohol and other CNS depressants
Serious warnings
- Increased risk of suicidality in children and adolescents
- Serotonin syndrome
- Withdrawal symptoms upon discontinuation
Important Disclaimer
The Paroxetine Unicorn 20 20 mg Tablets. professional information leaflet below is the property of Unicorn Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
